Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Ohara

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
World Neurosurgery|August 31, 2018
Difference in Immunosuppressive Cells Between Peritumoral Area and Tumor Core in GlioblastomaRyota Tamura, Kentaro Ohara, Hikaru Sasaki, et al.
Urologia Internationalis|December 14, 2018
Immunoglobulin G4-Related Disease Arising from the Bladder WallRyohei Kufukihara, Naoya Niwa, Ryuichi Mizuno, et al.
Journal of Neuro-Oncology|November 28, 2019
Tumor immune microenvironment is associated with the growth of intracranial germinomasMasaaki Nishimoto, Kentaro Ohara, Dai Kamamoto, et al.
Internal Medicine (Tokyo, Japan)|March 13, 2018
Secondary Brain Neoplasm after Stereotactic Radiosurgery in Patients with Metastatic Non-small Cell Lung CancerShigenari Nukaga, Katsuhiko Naoki, Hiroyuki Yasuda, et al.
World Neurosurgery|March 14, 2019
A Case of Aggressive Recurrent Intracranial Subdural Hematoma Associated with Angiosarcoma Originating from the SkullTokunori Kanazawa, Tomoru Miwa, Takenori Akiyama, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 20, 2020
Immunohistochemistry for O<sup>6</sup>-methylguanin-DNA methyltransferase in glioblastomas defined by WHO2016: Correlation with promoter methylation status and patients' progression-free survival with the cut-off value determined by ROC analysisEriel Sandika Pareira, Yuki Kitano, Kentaro Ohara, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 20, 2019
Immunological and vascular characteristics in cavernous sinus meningiomaKenzo Kosugi, Ryota Tamura, Kentaro Ohara, et al.
Nano Letters|May 5, 2021
Confinement and Protection of Skyrmions by Patterns of Modified Magnetic PropertiesKentaro Ohara, Xichao Zhang, Yinling Chen, et al.
World Neurosurgery|July 2, 2017
Clinical and Molecular Prognostic Factors for Long-Term Survival of Patients with Glioblastomas in Single-Institutional Consecutive CohortYu Nakagawa, Hikaru Sasaki, Kentaro Ohara, et al.
Endocrine Pathology|March 24, 2019
PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus InvasionRyota Tamura, Kentaro Ohara, Yukina Morimoto, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
World Neurosurgery|August 31, 2018
Difference in Immunosuppressive Cells Between Peritumoral Area and Tumor Core in GlioblastomaRyota Tamura, Kentaro Ohara, Hikaru Sasaki, et al.
Urologia Internationalis|December 14, 2018
Immunoglobulin G4-Related Disease Arising from the Bladder WallRyohei Kufukihara, Naoya Niwa, Ryuichi Mizuno, et al.
Journal of Neuro-Oncology|November 28, 2019
Tumor immune microenvironment is associated with the growth of intracranial germinomasMasaaki Nishimoto, Kentaro Ohara, Dai Kamamoto, et al.
Internal Medicine (Tokyo, Japan)|March 13, 2018
Secondary Brain Neoplasm after Stereotactic Radiosurgery in Patients with Metastatic Non-small Cell Lung CancerShigenari Nukaga, Katsuhiko Naoki, Hiroyuki Yasuda, et al.
World Neurosurgery|March 14, 2019
A Case of Aggressive Recurrent Intracranial Subdural Hematoma Associated with Angiosarcoma Originating from the SkullTokunori Kanazawa, Tomoru Miwa, Takenori Akiyama, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 20, 2020
Immunohistochemistry for O<sup>6</sup>-methylguanin-DNA methyltransferase in glioblastomas defined by WHO2016: Correlation with promoter methylation status and patients' progression-free survival with the cut-off value determined by ROC analysisEriel Sandika Pareira, Yuki Kitano, Kentaro Ohara, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 20, 2019
Immunological and vascular characteristics in cavernous sinus meningiomaKenzo Kosugi, Ryota Tamura, Kentaro Ohara, et al.
Nano Letters|May 5, 2021
Confinement and Protection of Skyrmions by Patterns of Modified Magnetic PropertiesKentaro Ohara, Xichao Zhang, Yinling Chen, et al.
World Neurosurgery|July 2, 2017
Clinical and Molecular Prognostic Factors for Long-Term Survival of Patients with Glioblastomas in Single-Institutional Consecutive CohortYu Nakagawa, Hikaru Sasaki, Kentaro Ohara, et al.
Endocrine Pathology|March 24, 2019
PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus InvasionRyota Tamura, Kentaro Ohara, Yukina Morimoto, et al.
Pageof 7